|
To ensure you receive F1000 emails, add
info@updates.f1000.com
to your safelist.
If this email is not displaying properly, please
view in your usual browser.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 2014
|
|
|
|
|
|
Beat Ebola with better research sharing
F1000Research has launched an Ebola article collection to enable all Ebola-related knowledge to be made available on a single platform within days of submission. All articles submitted to this collection will be prioritized and published free of charge. F1000Research has a dedicated phone line (+442071931030) to enable those working in affected areas to dictate their reports directly.
|
|  |
Peter Piot, the co-discoverer of virus, has also published an Editorial in F1000Research appealing for everyone working on the current epidemic to publish all their findings and experiences rapidly and openly. In addition, all F1000Prime Ebola and Marburg virus Article Recommendations are free to access.
Read more on our blog. |
|
|
|
|
|
|
|
 |
|
|
|
Below is a selection of recommendations added by our Faculty of 10,000+ Members over the past month:
|
|
|
|
11
★
|
|
Viral hijack
|
|
|
This paper helps to clarify how RNA viruses can exploit cellular microRNAs to reduce innate immune responses in mammalian cells.
Trobaugh DW, Gardner CL, Sun C et al.
Nature. 2014; 506:245-8
|
|
|
|
9
★
|
|
Promoting pathogenicity
|
|
|
This paper presents a fascinating story about itaconic acid, which is essential for the survival of pathogens such as Yersinia pestis and Salmonella enterica in target host cells.
Sasikaran J, Ziemski M, Zadora PK et al.
Nat Chem Biol. 2014; 10:371-7
|
|
|
|
7
★
|
|
Ceritinib vs. crizotinib
|
|
|
A ground-breaking phase I study shows that ceritinib is 20 times more potent than crizotinib against anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung carcinoma.
Shaw AT, Kim DW, Mehra R
et al.
N Engl J Med.
2014; 370:1189-97
|
|
|
|
F1000Prime Reports
|
|
|
|
Open-access review journal, reporting on the hottest topics.
|
|
|
|
Image credit: Nephron, Wikipedia
|
|
|
Management of lymphangioleiomyomatosis
Recent advances in understanding the causes of lymphangioleiomyomatosis (LAM) offer new hope for therapies targeting RhoA GTPases, which are currently undergoing phase 1 clinical testing.
F1000Prime Report
by Taveira-DaSilva AM, and Moss J.
F1000Prime Rep
2014,
6:116
See all recent
F1000Prime Reports.
|
|
|
|
|
|
|
|
|
|
Our innovative
open science publishing platform
offering rapid publication, open peer review and open data.
Below is a selection of our latest peer reviewed articles:
|
|
|
RESEARCH ARTICLE
Late cardiac sodium current can be assessed using automated patch-clamp [v1; ref status: indexed,
http://f1000r.es/4kj]
Published: 16 Oct 2014
Chevalier m, Amuzescu B, Gawali V et al.
F1000Research
2014, 3:245 |
|
|
RESEARCH ARTICLE
CaMKII binding to GluN2B is important for massed spatial learning in the Morris water maze
[v1; ref status: indexed,
http://f1000r.es/3ud]
Published: 12 Aug 2014
Stein IS, Donaldson MS, Hell JW.
F1000Research
2014, 3:193 |
|
|
RESEARCH ARTICLE
False memory susceptibility is correlated with categorisation ability in humans
[v2; ref status: indexed,
http://f1000r.es/4k0]
Published: 16 Oct 2014
Hunt K, Chittka L.
F1000Research
2014, 3:15 |
|
|
OBSERVATION ARTICLE
Plasmodium falciparum infection rates for some Anopheles spp. from Guinea-Bissau, West Africa
[v2; ref status: indexed,
http://f1000r.es/4n3]
Published: 05 Nov 2014
Sanford MR, Cornel AJ, Nieman CC et al.
F1000Research
2014,
3:243
|
|
|
|
|
|
| CiteAb Antibody Awards |
|
|
|
|
|
| We have partnered with CiteAb to deliver the very first CiteAb Antibody Awards! We recently launched our Antibody Validation Collection, and these awards are great way to recognise companies and individuals working with and creating antibodies. Make an award nomination or find out more here! http://www.citeab.com/awards
|
|
|
|
|
|
|
|
|
|
|
|
Open Repository
for posters and slide presentations; completely free to view and submit. Below is a selection:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In addition to this Monthly Update, we also send out emails featuring deals and discounts for registered users. To sign up, registered users should visit MyF1000 via any F1000 product and opt-in to receive "Information from F1000 about special offers" (under Email Alerts).
You have received this message because you asked to receive the F1000 Monthly Update to your registered email address from Faculty of 1000. If you do not wish to receive any further such messages, you may
unsubscribe
at any time.
For further information or enquiries please contact Customer Services at
info@f1000.com
.
Faculty of 1000 Ltd | Science Navigation Group
Registered in England and Wales with Company Number 3739756
Middlesex House, 34-42 Cleveland Street | London, W1T 4LB | United Kingdom
|
|
|
